HAVCR2 and cancer: A deeper understanding of the physiopathological role of the TIM-3 pathway in innate immunity will shed new light on the pathogenesis of clinical diseases such as autoimmune diseases, chronic viral infections, and cancer, and suggest new approaches to intervention.